Literature DB >> 11422126

Pathogenesis of systemic lupus erythematosus (SLE).

M G Robson1, M J Walport.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11422126     DOI： 10.1046/j.1365-2222.2001.01147.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  14 in total

1.  Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.

Authors:  M Youd; C Blickarz; L Woodworth; T Touzjian; A Edling; J Tedstone; M Ruzek; R Tubo; J Kaplan; T Lodie
Journal:  Clin Exp Immunol       Date:  2010-04-29       Impact factor: 4.330

Review 2.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

3.  Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.

Authors:  M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Mohamed Tarek; Javier Cáceres Del Carpio; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; Marquis P Vawter; S Michal Jazwinski; Michael V Miceli; Douglas C Wallace; Nitin Udar
Journal:  Biochim Biophys Acta       Date:  2013-11-04

Review 4.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

5.  DNase II polymorphisms associated with risk of renal disorder among systemic lupus erythematosus patients.

Authors:  Hyoung Doo Shin; Byung Lae Park; Hyun Sup Cheong; Hye-Soon Lee; Jae-Bum Jun; Sang-Cheol Bae
Journal:  J Hum Genet       Date:  2005-02-19       Impact factor: 3.172

6.  The role of CD4CD25 T cells in autoantibody production in murine lupus.

Authors:  W-T Hsu; J-L Suen; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

Review 7.  Possible novel biomarkers of organ involvement in systemic lupus erythematosus.

Authors:  Dinglei Su; Rui Liu; Xia Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-03-06       Impact factor: 2.980

8.  CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms.

Authors:  Èlia Ripoll; Ana Merino; Immaculada Herrero-Fresneda; Josep M Aran; Montse Goma; Nuria Bolaños; Laura de Ramon; Oriol Bestard; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea.

Authors:  Yoshiya Tanaka; Sang-Cheol Bae; Damon Bass; Paula Curtis; Myron Chu; Kathleen DeRose; Beulah Ji; Regina Kurrasch; Jenny Lowe; Paige Meizlik; David A Roth
Journal:  RMD Open       Date:  2021-07

Review 10.  Update on Biologic Therapies for Systemic Lupus Erythematosus.

Authors:  Helena Hiemisch Lobo Borba; Andreas Funke; Astrid Wiens; Shirley Ramos da Rosa Utiyama; Cássio Marques Perlin; Roberto Pontarolo
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.